Endocytic pathways regulate Toll‐like receptor 4 signaling and link innate and adaptive immunity

Harald Husebye, Øyvind Halaas, Harald Stenmark, Gro Tunheim, Øystein Sandanger, Bjarne Bogen, Andreas Brech, Eicke Latz, Terje Espevik

Author Affiliations

  1. Harald Husebye1,,
  2. Øyvind Halaas1,,
  3. Harald Stenmark1,3,
  4. Gro Tunheim2,
  5. Øystein Sandanger1,
  6. Bjarne Bogen2,
  7. Andreas Brech3,
  8. Eicke Latz4 and
  9. Terje Espevik*,1
  1. 1 Institute of Cancer Research and Molecular Medicine, The Norwegian University of Science and Technology, Trondheim, Norway
  2. 2 Institute of Immunology, Rikshospitalet University Hospital, Oslo, Norway
  3. 3 Department of Biochemistry, The Norwegian Radiumhospital, Oslo, Norway
  4. 4 Division of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, MA, USA
  1. *Corresponding author. Institute of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, 7489 Trondheim, Norway. Tel.: +47 7359 8668; Fax: +47 7359 8801; E‐mail: terje.espevik{at}
  1. These authors contributed equally to this work

View Full Text


Immune responses are initiated when molecules of microbial origin are sensed by the Toll‐like receptors (TLRs). We now report the identification of essential molecular components for the trafficking of the lipopolysaccharide (LPS) receptor complex. LPS was endocytosed by a receptor‐mediated mechanism dependent on dynamin and clathrin and colocalized with TLR4 on early/sorting endosomes. TLR4 was ubiquitinated and associated with the ubiquitin‐binding endosomal sorting protein hepatocyte growth factor‐regulated tyrosine kinase substrate, Hrs. Inhibition of endocytosis and endosomal sorting increased LPS signaling. Finally, the LPS receptor complex was sorted to late endosomes/lysosomes for degradation and loading of associated antigens onto HLA class II molecules for presentation to CD4+ T cells. Our results show that endosomal trafficking of the LPS receptor complex is essential for signal termination and LPS‐associated antigen presentation, thus controlling both innate and adaptive immunity through TLR4.


The Toll‐like receptors (TLRs) are key initiators of innate and adaptive immune responses through production of proinflammatory cytokines and chemokines, upregulation of costimulatory molecules and activation of antigen presentation (Akira and Takeda, 2004). The signaling receptor for lipopolysaccharide (LPS) is TLR4/MD‐2 receiving LPS from CD14. MD‐2 is a small, secreted glycoprotein that associates with TLR4 in a gp96‐dependent manner in the ER. MD‐2 is necessary both for translocation of TLR4 from Golgi to the surface (Nagai et al, 2002) and LPS‐induced activation (Shimazu et al, 1999). LPS delivered by CD14 to TLR4/MD‐2 initiates a signaling cascade through the Toll/interleukin‐1 receptor (TIR)‐adaptors MyD88, TIRAP (also known as Mal), TRIF and TRAM, which eventually leads to nuclear translocation of the proinflammatory transcription factor NFκB (Akira and Takeda, 2004). After LPS has engaged CD14, LPS is transported into Golgi‐like structures together with TLR4 (Thieblemont and Wright, 1999; Latz et al, 2002).

Excessive host responses towards LPS may lead to life‐threatening complications such as septic shock, multiorgan failure and death (Waage et al, 1989). Thus, it is instrumental that LPS‐induced responses are finely tuned. Part of the desensitization to LPS in human monocytes is caused by downregulation of surface TLR4/MD‐2 (Kitchens et al, 1998). Furthermore, several negative regulators of TLR4 signaling have been reported, such as IRAK‐M, short MyD88, SOCS‐1, SIGIRR, ST‐2, Tollip, A20, Triad3A (Liew et al, 2005), and recently DAP12 (Hamerman et al, 2005). Some of these negative regulators interfere with signaling molecules, whereas others, like Triad3A (Chuang and Ulevitch, 2004) and A20 (Boone et al, 2004), promote ubiquitin‐dependent degradation of TLRs or signaling components, respectively. Little is known about the mechanisms of the endosomal degradation pathway of the TLRs, and if this pathway serves important functions for TLR4 and associated LPS co‐receptors.

We undertook this study to delineate the mechanism by which the activated receptor complex is trafficked after engaging LPS. We have characterized the molecular mechanisms of endocytic trafficking of the LPS receptor complex and found important functional consequences of the lysosomal degradation pathway, both for the termination of signaling and the presentation of associated antigens to the CD4+ T helper cells.


LPS downregulates plasma membrane TLR4 and both appear on endosomes

During the early hours of incubation with LPS, a gradual decrease in plasma membrane TLR4 was observed in monocytes (Figure 1A). This occurred concomitantly with formation of endosome‐like structures containing LPSCy5 (Figure 1B, upper panel). At later time points, LPS accumulated in the perinuclear area (Figure 1B, lower panels). For the detection of TLR4, a TLR4 antibody (anti‐TLR4A546) was added simultaneously with fluorescent LPS (LPSOG) to monocytes. Colocalization of TLR4 and LPS was observed in microdomains on the endosomal limiting membrane 1 h after stimulation (Figure 1C).

Figure 1.

The LPS receptor complex is endocytosed and appears on endosomal structures in human monocytes. (A) Flow cytometry showing downregulation of surface TLR4. The surface TLR4 level was monitored in monocytes before and after LPS (2 ng/ml) stimulation using the TLR4 antibody HTA125 and the mouse IgG2a as an isotype control. (B) Confocal images of monocytes stimulated with Cy5‐labeled LPS (LPSCY5). The monocytes were incubated with LPSCy5 (250 ng/ml) and monitored over a period of 5 h. Arrows indicate LPS‐positive endosomal structures. (C) Confocal images of monocytes stimulated with OregonGreen‐labeled LPS (LPSOG) and coincubated with Alexa546‐labeled HTA125 (anti‐TLR4A546). Images were captured 1 h after addition of anti‐TLR4A546 (2 μg/ml) and LPSOG (600 ng/ml). No uptake was observed for the Alexa546‐labeled mouse isotype control IgG2a (2 μg/ml) (data not shown). Bar=5 μm.

We went on to study the localization and transport of TLR4 fused to YFP (TLR4YFP) in live HEK293 cells expressing the co‐receptors MD‐2 and CD14 using confocal microscopy and LPSCY5 for stimulation. In unstimulated cells, TLR4YFP was found in the endoplasmic reticulum, at the plasma membrane, as a large pool in the Golgi area and sporadically on endosomal structures (Figure 2A). Following LPS stimulation, endosomes showing LPS and TLR4 colocalization appeared within 15 min, suggesting active endocytosis (Figure 2A and B). Addition of LPS increased the number of TLR4‐containing endosomes seven‐fold within the first 40 min of stimulation and this increase was dependent on the co‐receptor MD‐2 (Figure 2B and C). Although we found endosomes containing TLR4 and LPS in the absence of MD‐2, the presence of MD‐2 enhanced the process, and also promoted aggregation of TLR4 in patches on the endosomes, as seen in Figure 1C and upper right panel of Figure 2A. CD14 greatly increased both binding to the surface and uptake of LPS, as has previously been reported (Kitchens et al, 1998; Latz et al, 2002).

Figure 2.

LPS is internalized on early endosomes containing TLR4. HEK293 cells expressing TLR4YFP/MD‐2 or TLR4YFP only were transfected with CD14 and stimulated by adding LPSCy5 (250 ng/ml). (A) Confocal images before (left) and 30 min after (right) the addition of LPSCy5. (B) Estimation of the number TLR4YFP‐containing endosomes (>0.5 μm) before and after stimulation. The TLR4YFP‐containing endosomes were counted in living cells without stimulation and in the period 10–40 min after LPSCy5 stimulation. The number of cells analyzed were n=52 cells for each situation. (C) Comparison of the number of TLR4YFP‐containing endosomes (>0.5 μm) with and without coexpression of MD‐2. The LPS‐positive endosomes with TLR4 colocalization was quantified as above in CD14‐transfected cells expressing TLR4YFP/MD‐2 (n=85) or cells expressing TLR4YFP (n=103). (D) Confocal images of cells showing colocalization of TLR4 and LPS on early/sorting endosomes. HEK293 cells expressing TLR4YFP/MD‐2 cotransfected with CD14 and the marker for early/sorting endosomes, 2 × FYVECFP, 45 min after the addition of LPSCy5. (E) Confocal image of a cell transfected as in (D) and simultaneously given Alexa546‐labeled transferrin TfA546 (5 μg/ml) and LPSCy5. Full‐sized images of each of the four channels of the overlaid image are shown in Supplementary Figure 2. All the images presented in this figure represent optical sections of 1.3 μm and one individual scan per cell was used for the counting of TLR4‐positive endosomes. Bar=5 μm.

LPS and TLR4 are trafficked to early/sorting endosomes

We further characterized the compartments into which LPS and TLR4 were sorted. Since LPS binding to the surface was only detected in cells expressing CD14, we subsequently used LPS binding as a marker for cells that had been successfully transfected with the CD14 plasmid. To characterize the TLR4‐positive endosomes, cells were transfected with plasmids encoding CD14 and a CFP chimera containing tandem FYVE domains from the mouse Hrs (2 × FYVECFP). This construct binds phosphatidylinositol‐3‐phosphate (PI3P) that is highly enriched on early/sorting endosomes (Gaullier et al, 1998; Simonsen et al, 1998; Gillooly et al, 2000). Within the first hour of LPS stimulation, most endosomes containing TLR4 and LPS were FYVE positive (Figure 2D). Endosomes containing TLR4 and LPS, and identified by 2 × FYVECFP, were also positive for transferrin (Figure 2E, Supplementary Figure 2). Transferrin is endocytosed in a clathrin‐dependent manner and sorted on early/sorting endosomes. In cells stimulated for longer periods, TLR4 and LPS appeared on endosomes being FYVE negative (data not shown). TLR4 showed extensive colocalization with LPS in all compartments. The localization of TLR4 to early endosomes was also confirmed by staining fixed cells with an antibody to the early endosomal marker EEA1 (data not shown) or by cotransfecting the cells with a truncated but functional EEA1 (Stenmark et al, 1996) fused to CFP (EEA1CFP). In unstimulated cells, TLR4 was present on small EEA1CFP‐positive endosomes that grew significantly larger in size after LPS stimulation (Supplementary Figure 1A). These EEA1‐positive endosomes, like the FYVE‐positive endosomes, contained a substantial amount of LPS and TLR4 on the limiting membrane. In addition, images were obtained demonstrating apparent fusion events between LPS‐positive endosomes (Supplementary Figure 1B and Supplementary Movie). Taken together, our data show that LPS and TLR4 are trafficked to early/sorting endosomes and that LPS‐induced signaling increases the size of these endosomes probably by endosome–endosome fusions.

LPS is endocytosed by a receptor‐mediated mechanism involving dynamin and clathrin

Receptor‐mediated endocytosis is often classified by being clathrin‐dependent (through coated pits as seen with transferrin) or clathrin‐independent (through caveoli or lipid rafts as seen for many glycosylphosphatidylinositol (GPI)‐anchored proteins). Both mechanisms are dependent on dynamin, whereas (macro)pinocytosis is dependent on actin (Nichols, 2003). Dynamin proteins are GTPases that are essential for budding of vesicles from the plasma membrane and from recycling endosomes. Whereas transmembrane proteins contain sorting information in the cytosolic domain, GPI‐anchored proteins (like CD14) have, in general, been shown to either be coendocytosed with the transmembrane proteins or pinocytosed together with fluid phase contents (Mayor and Riezman, 2004). We next investigated whether LPS endocytosis was dependent on dynamin using constructs of dynamin II wild type (WT) and dominant negative dynamin II (Dyn K44A) (Damke et al, 1994). Cells expressing TLR4YFP/MD‐2 were cotransfected with CD14 and dynamin WT or Dyn K44A, and investigated by confocal microscopy (Figure 3A). Fluorescent transferrin and LPS were added together for selection of cells with a dynamin knock down phenotype. LPS and transferrin uptake were not affected in the dynamin WT transfectants (Figure 3A, left panel), whereas in the Dyn K44A transfectants (Figure 3A, right panel) a clear accumulation of transferrin on the plasma membrane was observed and, as a consequence, reduced transferrin uptake (Damke et al, 1994). In DynK44A transfectants, total LPS uptake was reduced to about 18% of the uptake in dynamin WT transfectants (Figure 3B), supporting that LPS is endocytosed by a receptor‐mediated vesicular mechanism.

Figure 3.

Endocytosis of the LPS receptor complex is dependent on dynamin and clathrin. (A) Confocal images of dynamin WT (left)‐ and Dyn K44A (right)‐transfected cells. HEK293 cells expressing TLR4YFP/MD‐2 were transfected with CD14 together with dynamin WT or Dyn K44A and left for 6 days before analysis. The cells were simultaneously given LPSCy5 (250 ng/ml) and Alexa546‐labeled transferrin (TfA546) (5 μg/ml) and imaged after 50 min. (B) Comparison of the total LPS uptake in dynamin WT (n=46)‐ and Dyn K44A (n=52)‐transfected cells in fixed cells 75 min after LPSCy5 stimulation. The LPS uptake was quantified using the LSM510 software by measuring total intracellular fluorescence in manually drawn regions of interest and the number of cells analyzed were n=46 for the dynamin WT and n=52 for the Dyn K44A transfectants. (C) Confocal images of control siRNA‐treated cells (left) and clathrin siRNA‐treated cells (right) following LPSCy5 stimulation. HEK293 cells expressing TLR4YFP/MD‐2 were treated with control or clathrin siRNA for 48 h followed by a 24 h transfection with CD14. The cells were simultaneously given LPSCy5 (250 ng/ml) and TfA546 (5 μg/ml) and imaged after 35 min. (D) Comparison of the number of LPS‐positive endosomes (>0.5 μm) per cell in cells transfected with control siRNA and clathrin siRNA 10–40 min after LPSCy5 stimulation. The number of cells monitored was n=33 (control siRNA) and n=25 (clathrin siRNA). Clathrin‐ and control siRNA‐treated HEK293 cells transfected with CD14 alone were included for comparison (n=40 and 16, respectively). Bar=10 μm.

Clathrin is a scaffold protein involved in assembly of selected transmembrane proteins in invaginations called clathrin‐coated pits. We knocked down clathrin heavy chain by short interfering (si) RNA technology (Motley et al, 2003) in HEK293 cells expressing TLR4YFP/MD‐2 including a noninterfering scrambled RNA duplex (Bache et al, 2003) as a control. Following siRNA treatment, the cells were transfected with CD14 and the uptake and distribution of LPS and transferrin were investigated (Figure 3C). The introduction of control siRNA did not affect LPS and transferrin uptake (Figure 3C, left panel), whereas clathrin siRNA resulted in significant accumulation of both transferrin and LPS at the plasma membrane in these cells (Figure 3C, right panel). Cells showing accumulation of transferrin at the plasma membrane were scored as clathrin knock down transfectants. In these cells, LPS did not appear on endosomes during the first 40 min of stimulation (Figure 3C and D). At later time points, LPS appeared on large endosomes also positive for transferrin (data not shown), suggesting an additional but slower clathrin‐independent uptake mechanism. As we found siRNA against clathrin to be very effective in inhibiting both transferrin and LPS uptake, our results show clathrin to be an essential component for the early endocytosis of the LPS receptor complex.

TLR4 is ubiquitinated and associates with Hrs

The targeting of transmembrane proteins to lysosomes is determined by tyrosine phosphorylation and di‐leucin motifs of which there are candidates in TLR4. Tyrosine‐based motifs (YXXΦ) are found in positions 587 (YDAF), 622 (YRDF) and 707 (YLEW), whereas a di‐leucine motif ([DE]XXXL[LI]) is found in position 697 (ELYRLL), both recognized by adaptor protein (AP) complexes involved in the initial phase of endocytosis (Bonifacino and Traub, 2003). A major additional mechanism for endocytosis and lysosomal targeting of transmembrane proteins is by the covalent attachment of one or more ubiquitins to lysines to the cytosolic domain (Hicke, 2001; Raiborg et al, 2003). A recent report showed that the E3 ubiquitin ligase Triad3A was involved in degradation of TLRs (except TLR2) (Chuang and Ulevitch, 2004). Thus, we wanted to address if LPS induced ubiquitination of TLR4 and if this had any effect on endocytosis and degradation of TLR4. We found that TLR4 ubiquitination was both constitutive and enhanced by LPS in HEK293 cells expressing TLR4YFP/MD‐2 (Figure 4A). In monocytes, a weak increase in ubiquitination of TLR4 was observed at 1 h of LPS stimulation, followed by a reduction after 3 h (Figure 4B). TLR4 was ubiquitinated in cells transfected with c‐myc Ub wild type (UbRGG) but not in cells transfected with a c‐myc nonfunctional Ub (UbR) lacking the two C‐terminal glycines required for covalent conjugation to proteins (data not shown) (Stang et al, 2004). There was, however, no effect of UbR on uptake of LPS within the first hour of stimulation (data not shown), suggesting that LPS uptake is Ub‐independent. Ubiquitin ligases are recruited by their SH2 domains to tyrosine‐phosphorylated targets, and we found that TLR4 was indeed tyrosine phosphorylated in response to LPS (data not shown). These data suggest that although TLR4 is ubiquitinated as a response of LPS stimulation, ubiquitination is not required for the initial endocytosis of the LPS receptor complex.

Figure 4.

LPS promotes TLR4 ubiquitination and the association of TLR4 with Hrs. (A) HEK293 cells expressing TLR4YFP/MD‐2 were stimulated with LPS (1 μg/ml) for the indicated time periods. TLR4YFP was immunoprecipitated with a polyclonal anti‐GFP antibody and blotted for ubiquitin (FK2 antibody) and GFP (monoclonal GFP antibody). (B) Monocytes were either left untreated or stimulated with LPS (1 μg/ml) for the indicated time periods. Cellular lysates were made and TLR4 immunoprecipitated with a polyclonal TLR4 antibody and blotted for ubiquitin (left), TLR4 (middle) and Hrs (lower left) or the reverse immunoprecipitatation of Hrs or control IgG blotted for TLR4 (upper right). The Hrs in lysate is shown in the lower right panel. (C) HEK293 cells expressing TLR4YFP/MD‐2 were transfected with c‐myc Hrs for 24 h before LPS stimulation for the indicated periods. Cellular lysates were prepared and immunoprecipitated with anti‐GFP (TLR4YFP) or control IgG (C1) and blotted for Hrs. Control C2 represents Hrs immunoprecipitated from nontransfected HEK293 cells showing the size of endogenous Hrs. Overexpression of Hrs resulted in an LPS‐induced reduction in TLR4 levels in lysates, whereas Hrs and tubulin levels are unaffected (lower three panels). (D) Confocal images of HEK293 cells expressing TLR4CFP/MD‐2 transfected with CD14 and HrsYFP following 3 h of LPS (250 ng/ml) stimulation. Bar=5 μm.

Hrs is located to clathrin‐coated microdomains of the early/sorting endosomal limiting membrane where it is involved in the recognition and targeting of ubiquitinated protein cargo to the lysosomal degradation pathway by promoting translocation of the target proteins to the lumen of endosomes forming multivesicular bodies (MVB) (Gruenberg and Stenmark, 2004). Hrs has recently also been shown to associate with phagosomes and aid in fusion with lysosomes (Vieira et al, 2004). We investigated the involvement of Hrs in TLR4 trafficking in monocytes and in HEK293‐TLR4YFP/MD‐2 cells transiently transfected with c‐myc‐tagged Hrs. In monocytes Hrs constitutively associated with TLR4; however, the association increased transiently after 1 h of LPS stimulation (Figure 4B). Control IgG did not co‐precipitate TLR4 (Figure 4B) or Hrs (data nor shown). The TLR4 immunoprecipitated with Hrs was slightly larger and appeared more smeared than the mature form of TLR4 (Figure 4B, middle), possibly because Hrs interacts mainly with multiple ubiquitins on the intracellular domain of TLR4. Also in HEK293 cells overexpressing c‐myc‐Hrs, we found that TLR4 co‐precipitated with Hrs (Figure 4C) in an LPS‐inducible manner, whereas control IgG did not (control C1, Figure 4C). The upper band in Figure 4C represents the c‐myc‐tagged Hrs and the lower band is the endogenous Hrs as shown by comigration with the endogenous Hrs from nontransfected HEK293 cells (control C2, Figure 4C). Importantly, a moderate overexpression of c‐myc Hrs (here estimated to be less than three times the endogenous level) lead to a rapid decrease in the amount of total cellular TLR4 after addition of LPS, whereas the amounts of Hrs and tubulin were unaffected (Figure 4C). This result is in accordance with a recent paper (Scoles et al, 2005), which demonstrated that overexpression of Hrs (e.g. less than 10 times the endogenous level) results in a rapid decrease in the EGFR levels upon stimulation with EGF. Furthermore, TLR4CFP and HrsYFP were colocalized on discrete microdomains on the endosomal limiting membrane following LPS stimulation (Figure 4D).

TLR4 is trafficked to lysosomes for degradation

Next, we investigated the effect of chloroquine and lactacystin on TLR4 levels following LPS stimulation in HEK293 cells expressing TLR4YFP/MD‐2 and transfected with CD14. Chloroquine inhibits maturation of early endosomes to lysosomes by inhibiting acidification and thus preventing lysosomal degradation (Mellman et al, 1986). Lactacystin is an irreversible proteasome inhibitor. Previous studies have shown that cellular TLR4 is present in two different sizes, the larger is a 130 kDa heavily glycosylated, MD‐2‐dependent, surface‐translocated form and the smaller is a 110 kDa partially glycosylated form found predominantly in Golgi (Nagai et al, 2002; Ohnishi et al, 2003). LPS seemed to increase the total cellular TLR4 after 10 h which may be due to increased transcription of the CMV‐promoted TLR4‐YFP constructs by LPS (Lee et al, 2004). However, 1 h of LPS stimulation did not increase the TLR4 level. Treatment with chloroquine resulted in a significant cellular accumulation of both forms of TLR4 as early as 1 h after LPS (Figure 5A). Interestingly, lactacystin reported to block Triad3A‐mediated degradation of TLR9 (Chuang and Ulevitch, 2004) did not cause the same accumulation of TLR4YFP in LPS‐stimulated cells (Figure 5A). LY294002 (LY) inhibits the PI3‐kinase enzymes responsible for the formation of the cellular PI3P controlling endosome fusions (Simonsen et al, 1998) and the formation of intraluminal vesicles in late endosomes/MVBs (Futter et al, 2001). PI3‐kinase activity is also required for the recruitment of Hrs to endosomal membranes (Komada and Soriano, 1999; Urbe et al, 2000). Cells treated with LY and stimulated with LPS showed a dramatic increase in the level of TLR4YFP after 10 h of LPS stimulation compared to LPS‐stimulated cells treated with control vehicle (Figure 5B). Altogether, these data suggest that endosomal sorting and acidification are required for degradation of TLR4.

Figure 5.

Lysosomal degradation of TLR4 limits signaling. (A) HEK293 cells expressing TLR4YFP/MD‐2 were transfected with CD14 and treated with chloroquine (10 μM) or lactacystin (10 μM) for 30 min prior to LPS (1 μg/ml) stimulation for the indicated time periods. Cellular lysates were made and TLR4YFP was detected using a polyclonal anti‐GFP antibody and reblotted for α‐tubulin as a control for equal loading. The samples displayed represent sections of the original blot. (B) HEK293 cells expressing TLR4YFP/MD‐2 were transfected with CD14 and treated with 10 μM LY or control vehicle (EtOH) for 30 min and stimulated with LPS (1 μg/ml) for 10 h. Cellular lysates were made and TLR4YFP was detected using a polyclonal anti‐GFP antibody and reblotted for α‐tubulin as a control for equal loading. (C) HEK293 cells expressing TLR4YFP/MD‐2 were treated with control of Hrs siRNA and transfected with CD14. Cellular lysates were made and blotted for GFP (TLR4YFP), Hrs, and α‐tubulin for the examination of TLR4YFP and Hrs levels. The samples displayed represent sections of the original blot. (D) Effect of dynamin and ubiquitination on LPS‐induced NFκB activation through TLR4. HEK293 cells expressing TLR4 were transfected with MD‐2, CD14 and Elam‐luc together with WT constructs (dynamin and UbRGG) or a dominant negative version of dynamin (Dyn K44A) or an inhibitory version of ubiquitin (UbR, lacking the two C‐terminal glycines necessary for conjugation to proteins but able to occupy ubiquitin‐binding pockets). The cells were stimulated for 6 h with LPS (10 ng/ml) and assayed for NFκB‐induced luciferase expression. (E) Effect of Hrs and ESCRT‐I on LPS‐induced NFκB activation through TLR4. HEK293 cells expressing TLR4YFP/MD‐2 were treated with control siRNA or siRNA directed towards Hrs or HCRP1 (component of ESCRT‐I) and cotransfected with CD14 and Elam‐luc as described in the Materials and methods section and assayed for NFκB‐induced luciferase expression.

Furthermore, we investigated the involvement of Hrs in TLR4 degradation by knocking down the endogenous level of Hrs by siRNA technology (Bache et al, 2003). Hrs siRNA‐treated HEK293 cells expressing TLR4YFP/MD‐2 and transfected with CD14 showed an increased levels of both the large fully glycosylated and the partially glycosylated TLR4YFP form compared to the cells treated with control siRNA (Figure 5C, upper panel). Our results suggest that ubiquitinated TLR4 associates with Hrs directing the activated TLR4 to lysososomes for degradation. This result is in contrast to TLR9 that has been reported to be degraded by proteasomes after ubiquitination by the Triad3A ubiquitin ligase (Chuang and Ulevitch, 2004).

Inhibition of the endosomal pathway increases LPS‐induced NFκB activation

After describing mechanisms of the TLR4 sorting through the endosomal pathway, we investigated the role of this pathway on LPS‐induced NFκB activation. By comparing the effect of wild‐type versus dominant negative constructs for the trafficking components dynamin II (dynamin WT versus Dyn K44A) and ubiquitin (UbRGG versus UbR), we found that the reduced endocytic activity caused by Dyn K44A, or saturation of Ub‐interacting proteins with the nonfunctional UbR, caused increased NFκB activation compared to overexpression of the WT constructs (Figure 5D and Supplementary Figure 3). This result strongly supports that signaling is initiated at the plasma membrane (Ahmad‐Nejad et al, 2002; Latz et al, 2002), and that endocytosis and lysosomal targeting of TLR4 limit NFκB activation. Additional arguments for this conclusion was also obtained in knock down experiments of Hrs with siRNA showing a 70% increase in LPS‐induced NFκB activation compared to control (Figure 5E and Supplementary Figure 3). Furthermore, by knocking down an essential component (HCRP1) of the endosomal sorting complexes required for transport‐I (ESCRT‐I) with siRNA (Bache et al, 2004), the LPS (10 ng/ml)‐induced NFκB activation increased by 245% compared to the siRNA control (Figure 5E). These data suggest that dynamin, ubiquitin, Hrs and HCRP1 (i.e. ESCRT‐I) are involved in desensitizing the cell after LPS activation, most likely through endocytosis and lysosomal degradation of the activated LPS receptor complex.

Antigens associated with the LPS receptor complex are presented on HLA class II to CD4+ T helper cells

Time‐lapse series of LPS‐stimulated monocytes showed that LPS overlapped with dextran in dynamic tubular structures protruding from the perinuclear area after 3–5 h of incubation (data not shown). These protrusions were directed towards the plasma membrane as has been described for MHC class II containing lysosome‐like tubulae after LPS stimulation in dendritic cells (Boes et al, 2002), a phenotype not observed in HEK293 cells. By counterstaining HEK293 cells expressing TLR4YFP/MD‐2 transfected with CD14 with an antibody against the late endosomal/lysosomal marker protein LAMP‐1, we observed that TLR4YFP was present in the lumen of late endosomes/MVBs following LPS stimulation (Figure 6A). Treatment of stimulated live cells with LysoTracker Red showed that TLR4YFP and LPSCY5 colocalized at the limiting membrane and in the lumen of nonacidic endosomes (Figure 6B). Intraluminal TLR4YFP was lost following endosomal acidification, whereas LPSCY5 was still detectable. Since TLR4 and LPS/CD14 are directed through the endocytic compartments to lysosomes for degradation, associated antigens may be presented on HLA class II to CD4+ T cells. We performed antigen presentation assays using mouse antibodies to TLR4 (HTA125), CD14 (5C5) and MD‐2 (IIC2) and proliferation of a CD4+ T cell specific for the mouse κ‐light chain‐derived peptide Cκ40–48 presented on HLA‐DR4 (Schjetne et al, 2002) in an LPS‐free system. This system is designed for functional testing of the class II presentation pathway by providing a read‐out for lysosomal antigen processing, loading and presentation in primary human cells. We found efficient presentation of the antibody‐derived peptide (Figure 6C) suggesting that TLR4, MD‐2 and CD14 were directed to a functional class II loading compartment, most commonly ascribed to MVB (Peters et al, 1991). This result implies that the LPS receptor complex, TLR4/MD‐2/CD14, not only signals the presence of microbes but also assists in directing the endocytosis of antigens on class II molecules for presentation to T helper cells.

Figure 6.

The LPS receptor complex is trafficked to the class II loading compartment. (A) Confocal images showing TLR4YFP in the lumen of LAMP‐1‐positive endosomes. HEK293 cells expressing TLR4YFP/MD‐2 transfected with CD14 were treated for 2 h with LPS (1 μg/ml) and fixed before intracellular staining for LAMP1. Arrows indicate LAMP‐1‐positive endosomes showing intraluminal TLR4YFP. (B) Confocal images showing TLR4YFP in the lumen of nonacidic endosomes. HEK293 cells expressing TLR4YFP/MD‐2 transfected with CD14 were stimulated with LPS (1 μg/ml) for 3 h and incubated with 10 nM LysoTracker Red (C). Antibodies towards TLR4 (HTA125), CD14 (5C5) or MD‐2 (IIC1) or isotype‐matched controls were added to human HLA‐matched monocytes together with cloned DR4‐restricted CD4+ T cells specific for mouse Cκ40–48. T‐cell proliferation was measured after 48 h by incorporation of [3H] TdR. Data points are mean of duplicates from a representative experiment. Isotype‐matched monoclonal antibodies were used as controls. Bar=5 μm.


Molecular mechanisms involved in sorting of the LPS receptor complex

The TLR4 agonist, LPS, is a potent immune stimulator which can cause sepsis. TLR4 signaling is under tight regulatory control at multiple levels and several inhibitors of TLR4 signaling have now been described. Internalization of receptors regulates signal transduction (Di Guglielmo et al, 2003); however, little attention has been devoted to mechanisms and functional consequences of the endocytic uptake of the LPS receptor complex. In this study, we have characterized the uptake of LPS and the sorting of the LPS receptor complex from the plasma membrane to the late endosomes/lysosomes and explored functional consequences of this endosomal pathway.

Internalization of membrane receptors occurs both through clathrin‐ and caveolae/raft‐mediated pathways. The EGF receptor is internalized within minutes after ligand addition by a clathrin‐mediated pathway (Le and Wrana, 2005), whereas the IL‐2 receptor appears to be taken up by a lipid raft‐dependent manner (Lamaze et al, 2001). Previous reports have shown that CD14 is located in lipid rafts and that a fraction of TLR4 moves into the lipid raft domain after LPS stimulation, a result suggesting a clathrin‐independent uptake of the LPS receptor complex (Triantafilou et al, 2004). Furthermore, Kitchens et al (1998) reported that the CD14‐mediated uptake of LPS occurs by both clathrin‐dependent and ‐independent pathways. Knocking down clathrin by siRNA results in a significant inhibition of EGF uptake at low EGF doses and less effective at higher EGF doses (Sigismund et al, 2005). Our results using siRNA for clathrin clearly demonstrate that the early phase (up to 40 min) of LPS internalization is predominantly clathrin‐dependent, whereas clathrin‐independent pathways operate at later time points.

Monoubiquitination serves an important role in sorting membrane proteins through the endosomal pathway (Raiborg et al, 2003), whereas polyubiquitination is the recognition signal for proteasomal degradation (Marmor and Yarden, 2004). As mentioned above, Triad3A has been reported to be an E3 ubiquitin ligase that promotes proteasomal degradation of TLR9 (Chuang and Ulevitch, 2004). Triad3A‐mediated ubiquitination does not seem to play a role in the lysosomal degradation pathway as the effect of this ligase on TLR9 degradation is dependent on proteasomal, but not lysosomal activity (Chuang and Ulevitch, 2004). We observed increased ubiquitination of TLR4 upon LPS activation both in monocytes and in genetically engineered cells. Hrs has an essential role in sorting ubiquitinated proteins into clathrin‐coated microdomains of early endosomes (Raiborg et al, 2002) and Hrs has interacting domains for PI3P (the FYVE domain), clathrin and ubiquitin (Bache et al, 2003). We provide evidence for Hrs interaction with TLR4 on endosomes and that this interaction was increased upon LPS activation. Thus, Hrs seems to play an important role in the initial steps of TLR4 sorting to the endosomal pathway. A part of the LPS receptor complex also traffics from the plasma membrane to the Golgi (Latz et al, 2002), and this pathway may either go directly from the plasma membrane or through the early/sorting endosomes. Whether Hrs also plays a role in TLR4 trafficking to the Golgi apparatus is not known. Another protein, Tollip, has been shown to inhibit LPS‐induced NFκB activation (Zhang and Ghosh, 2002) by a mechanism requiring localization to endosomes or activated plasma membranes and through binding of ubiquitinated cargo and recruitment to clathrin‐coated microdomains (Katoh et al, 2004), not unlike Hrs. It is thus likely that redundancy exists in the machinery that ensures that inflammatory signals are shut off to avoid hyperinflammation and the accompanied adverse effects.

Endosomal trafficking of the LPS receptor complex leading to lysosomal degradation and signal termination was consistently demonstrated in the HEK293‐TLR4 cells. Our results suggest that a similar pathway of LPS receptor endocytosis and degradation also operates in monocytes. Firstly, LPS induced a clear downregulation of TLR4 on the plasma membrane with subsequent localization of LPS and TLR4 to endosomes. Secondly, ubiquitination of TLR4 was constitutive, weakly increased after 1 h of LPS stimulation and markedly decreased after 3 h. Finally, TLR4 associated with Hrs and this association was transiently increased at 1 h of LPS stimulation. Direct evidence for LPS‐induced lysosomal degradation of TLR4 in monocytes was difficult to obtain due to low TLR4 signals in immunoblots and probably a high turnover rate for TLR4. However, antibodies towards TLR4, MD‐2 and CD14 were degraded in MVBs/lysosomes since an antibody‐derived peptide was loaded onto HLA class II (Figure 6C). Thus, it is likely that the pathway of endosomal degradation of TLR4 that we demonstrated in the HEK293‐TLR4 cells also, at least to some extent, takes place in monocytes.

Inhibition of endocytosis and endosomal sorting increase LPS‐induced proinflammatory signaling

Our studies provide evidence that sorting the LPS receptor complex through the endosomal pathway has important functional consequences. We observed a striking increase in LPS signaling when proteins involved in endosomal trafficking and maturation were inhibited. By reducing the amount of functional ESCRT‐I, which associates with Hrs and is involved in the sorting of ubiquitinated proteins into multivesicular bodies (Bache et al, 2002), a more than two‐fold increase in the LPS signaling was observed. Inhibition of ubiquitination and depletion of Hrs or ESCRT‐I resulted in increased LPS signaling. Furthermore, overexpression of Hrs lead to a significant increase in LPS‐induced TLR4 degradation. From these results it is apparent that LPS signaling starts at the plasma membrane; however, signaling is likely to continue along the endosomal pathway until an Hrs‐ and ESCRT‐I‐mediated translocation of TLR4 to the luminal side of endosomes has taken place. This view is also supported by confocal imaging showing the presence of the signaling adapters MyD88 and TRAM at the plasma membrane and on endosomes in LPS‐stimulated cells (H Husebye and T Espevik, unpublished results). Signaling on endosomes is also reported for TGF‐β which is taken up by a clathrin‐dependent mechanism and trafficked into early endosomes where the signaling component SARA is enriched (Di Guglielmo et al, 2003).

The LPS receptor complex links innate and adaptive immunity

A very important consequence of the trafficking of the LPS receptor complex described in this paper is that antigens associated with the LPS receptor complex are directly transported to the antigen presentation machinery for presentation to CD4+ T helper cells. The loading of antigens on class II molecules occurs by fusion of limiting and intraluminal membranes in MVBs (Peters et al, 1991), resulting in exchange of the class II inhibitory peptide (CLIP) with lysosomal peptides derived from processed exogenous proteins. This is also highly relevant for other suggested ligands of TLR4, like heat shock proteins, viral proteins (Akira and Takeda, 2004) and cotrafficked antigens, by providing a direct link between activation of innate and acquired immune cells. This may be exploited in design of synthetic vaccines aimed at the CD4+ T‐helper cell population, as has been shown for conjugated complexes of lipoproteins and immunogenic peptides acting through TLR2 (Jackson et al, 2004).

Altogether, our results strongly support that distinct components of the endocytic pathway inhibit inflammatory signals induced by TLR4 and that long‐lived information is simultaneously passed on to the adaptive branch of the immune system.

Materials and methods


LPS (0111:B4) from Escherichia coli was purchased from Invivogen. Cy5‐ and OregonGreen (OG) labeling of LPS was performed as previously described (Latz et al, 2002). Alexa labeling of antibodies was performed according to the manufacturer's protocol (Invitrogen). Alexa546‐labeled transferrin and LysoTracker Red were purchased from Invitrogen. LY294002 and lactacystin were purchased from Calbiochem. Chloroquine was purchased from Sigma. Mouse antibodies used: anti‐GFP (JL‐8) (Clontech), anti‐TLR4 (HTA125) was kindly provided by Dr Kensuke Miyake (Saga Medical School, Japan) (Yang et al, 2000), anti‐c‐myc (9E10) (BD Bioscience), anti‐ubiquitin‐protein conjugates (FK2) (Affiniti Research), anti‐LAMP1 (R&D Systems), anti‐CD14 (5C5) (Lien et al, 1998) and anti‐MD‐2 (IIC1). The mouse monoclonal antibody IIC1 (IgM) detects MD‐2 in CHO and HEK293 cells expressing TLR4/MD‐2 as well as on the surface of human monocytes (T Espevik and L Ryan, unpublished results). Rabbit polyclonal antibodies used: anti‐TLR4 (eBioscience), anti‐GFP (Clontech) and anti‐Hrs (Raiborg et al, 2001). The following mammalian expression vectors were used: pcDNA3 (Invitrogen), CD14 (Latz et al, 2002), c‐myc‐Hrs, c‐myc‐ubiquitin wild‐type UbRGG (Stang et al, 2004) and c‐myc‐ubiquitin DN UbR (Stang et al, 2004) were in pcDNA3. Dynamin‐II wild type and Dynamin‐II K44A in pcDNA3 were kindly provided by Dr Sandy Schmid (Scripps, USA). MD‐2 in pEF‐BOS was kindly provided by Dr Miyake (Yang et al, 2000). HrsYFP was in pEYFP‐C1 (Clontech). The ECFP‐2 × FYVE construct was made by substituting GFP from EGFP‐2 × FYVE (Gillooly et al, 2000) with CFP using pECFP (Clontech) as a template and PCR primers 5′‐CCA AGT ACG CCC CCT ATT GA‐3′ and 5′‐ATT TAA GCT TGT ACA GCT CGT CCA TGC‐3′. The CFP encoding fragment was inserted as an NheI/XhoI fragment.

Cells and cell lines

HEK293 cell lines that stably expressed human TLR4 (Yang et al, 2000), TLR4YFP, TLR4YFP/MD‐2 (Latz et al, 2002) or TLR4CFP/MD‐2 were used and cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal calf serum (FCS) and 0.5 mg/ml G418 and transfected using GeneJuice™ transfection reagent (Novagene) according to the manufacturer's protocol. Human monocytes were isolated by plastic adherence from Lymphoprep (Axis‐Shield) separated buffycoats (The Blood Bank, St Olavs Hospital, Trondheim, Norway) and grown in RPMI/10% pooled A+ serum (The Blood Bank). LPS was sonicated for 5 min and preincubated in serum‐containing medium at 37°C for 5 min before being added to cells. For confocal imaging, the cells were seeded on 35 mm glass bottom γ‐irradiated tissue cell dishes (MatTek Corporation) and buffered with 25 mM HEPES buffer just before stimulation. LPSCY5 (250 ng/ml) or LPSOG (600 ng/ml) was used in LPS uptake studies.

Flow cytometry

Adherent monocytes were incubated with or without LPS (100 ng/ml) in medium/10% A+ serum for 2 h, detached with EDTA and stained with 10 μg/ml anti‐TLR4 (HTA125) or mouse IgG2a for 30 min on ice, washed and incubated with 10 μg/ml secondary anti‐mouse Ig‐FITC (Becton Dickinson) for 30 min on ice and washed and analyzed by flow cytometry (Coulter).

Short interfering RNA treatment

SiRNA duplexes targeting the coding region of clathrin heavy chain (Motley et al, 2003), the coding region of Hrs (Bache et al, 2003) and the coding region of the ESCRT‐I component HCRP1 (Bache et al, 2004) were used. A scrambled RNA duplex (Bache et al, 2003) was used as a noninterfering control. All siRNA duplexes used were synthesized by Dharmacon. HEK293 cells and cells expressing TLR4YFP/MD‐2 were transfected with 20 nM siRNA for 48 h using Oligofectamine (Invitrogen) according to the manufacturer's protocol. For the silencing of Hrs and HCRP1, the cells were replated and subjected to a second round of siRNA treatment. For the introduction of plasmid DNA into the siRNA‐transfected cells, the cells were replated and transfected for 24 h using the GeneJuice transfection reagent.

Western blotting and immunoprecipitation

HEK293 cells expressing TLR4YFP were plated on 35 mm dishes and transfected 24–48 h before two washes in PBS and lysed in 100–300 μl of lysis buffer (20 mM Tris–HCl, 1 mM EDTA, 1 mM EGTA, 137 mM NaCl, 1% Triton X‐100, 1 mM sodium deoxycholate, 10% glycerol, 1 mM Na3VO4, 50 mM NaF and Complete protease inhibitor (Roche)). For Western blotting, the samples were denatured in 1 × NuPAGE LDS sample buffer supplemented with 25 mM DTT for 10 min at 70°C. Electrophoresis was performed using NuPAGE novex 7% Tris‐Acetate polyacrylamide or 10% Bis‐Tris polyacrylamide gels (Invitrogen) and the samples blotted onto 0.45 μm nitrocellulose filters (Biorad laboratories) and developed using ECL (Amersham Biosciences). For the analysis of immune complexes, lysates were precleared for 1 h with protein G Sepharose and subsequently incubated for 2 h with the appropriate antibody (2–3 μg/ml). Immune complexes were harvested with protein G Sepharose for 2 h before four washes in lysis buffer. Elution of the immune complexes was performed at 95°C for 10 min in 2 × LDS sample buffer supplemented with 50 mM DTT.

Confocal imaging

Images of live cells were captured at 37°C using an Axiovert 100‐M microscope with a heated stage equipped with a Zeiss LSM 510 META scanning unit and a 1.4 NA × 63 plan apochromat objective. For intracellular staining, the cells were permeabilized in 0.05% saponin, fixed in 3% paraformalaldehyde and incubated with the appropriate antibody as described previously (Simonsen et al, 1998). For LPS uptake studies in monocytes, fluorescently labeled LPS was added to the cells alone or simultaneously with 2 μg/ml Alexa546‐labeled anti‐TLR4 (HTA125) or 2 μg/ml Alexa546‐labeled isotype control. Only ring formed endosomes positive for TLR4 and/or LPS on the limiting membrane (minimal cutoff size 0.5 μm) were counted. The total intracellular LPS fluorescence in Figure 3B was quantified by manually drawing a region of interest that covered the cytoplasm and using the LSM510 software to calculate total fluorescence.

Antigen presentation

The human CD4+ Th1 cell clone (T18) specific for mouse antibody constant κ‐chain‐derived peptide Cκ40–48 and restricted by HLA‐DR4 (DRA1, B1*0401) was used to measure T helper‐cell responses (Schjetne et al, 2003). Antigen‐presenting cells used were HLA‐matched adherent peripheral blood monocytes (CD14+). Tissue culture medium was RPMI 1640 with glucose and l‐glutamine (Gibco, Paisley, Scotland) supplemented with pooled 10% human serum (HS) from blood donors.

Luciferase assay

NFκB activation was determined by an NFκB luciferase reporter assay as described (Latz et al, 2002).

Supplementary data

Supplementary data are available at The EMBO Journal Online.

Supplementary Information

Supplementary Movie 1 []

Supplementary Figures and Supplementary Movie Legend [emboj7600991-sup-0002.pdf]


We thank Liv Ryan for technical assistance. Professor Oddmund Bakke, University of Oslo, generously provided the EEA1CFP construct. This work was supported by The Norwegian Research Council, The Norwegian Cancer Society and the Commission of the European Communities, LSMH‐CT‐2004‐512093, AMIS. Andreas Brech is the recipient of a career scientist fellowship from the FUGE program of the Research Council of Norway. The authors have no conflicting financial interests.


View Abstract